Detalhe da pesquisa
1.
A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours.
Br J Cancer
; 130(7): 1131-1140, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38287179
2.
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer.
N Engl J Med
; 381(4): 307-316, 2019 07 25.
Artigo
Inglês
| MEDLINE | ID: mdl-31166679
3.
Practical implementation of the partial ordering continual reassessment method in a Phase I combination-schedule dose-finding trial.
Stat Med
; 41(30): 5789-5809, 2022 12 30.
Artigo
Inglês
| MEDLINE | ID: mdl-36428217
4.
Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer.
Cancer Sci
; 111(9): 3313-3326, 2020 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-32619077
5.
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial.
Lancet
; 393(10191): 2599-2612, 2019 06 29.
Artigo
Inglês
| MEDLINE | ID: mdl-31178152
6.
Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial.
Mod Pathol
; 30(8): 1069-1077, 2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28548129
7.
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study.
PLoS Med
; 13(12): e1002198, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27997533
8.
Trastuzumab-associated cardiac events in the Persephone trial.
Br J Cancer
; 115(12): 1462-1470, 2016 Dec 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27875516
9.
Intensive cisplatin/oral etoposide for epithelial ovarian cancer: the Cambridge Gynae-Oncology Centre experience: too toxic for relapse?
Anticancer Drugs
; 27(3): 239-44, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26575000
10.
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 16(6): 656-66, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25975632
11.
Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes - what does it all mean?
BMC Med
; 13: 234, 2015 Sep 22.
Artigo
Inglês
| MEDLINE | ID: mdl-26391216
12.
Molecular pathogenesis of ovarian clear cell carcinoma.
Future Oncol
; 11(9): 1389-405, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25952785
13.
Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study.
Int J Gynecol Cancer
; 25(6): 977-84, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-25962114
14.
Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial.
Lancet Oncol
; 15(2): 201-12, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24360787
15.
Trabectedin for advanced soft tissue sarcomas: a single institution experience.
Future Oncol
; 10(11): 1843-51, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-24450573
16.
First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors.
Clin Cancer Res
; 30(10): 2057-2067, 2024 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38407317
17.
Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays.
NPJ Precis Oncol
; 7(1): 103, 2023 Oct 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37821580
18.
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
; 190: 112950, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37441939
19.
Ovarian clear cell carcinoma--bad endometriosis or bad endometrium?
J Pathol
; 225(2): 157-60, 2011 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-21898874
20.
Survival of patients with metastatic breast cancer with or without locoregional therapy.
Lancet Oncol
; 16(16): e585, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26678205